Research of Safety and efficacy of the decelllerized human heart valve after the trasplantation to congenital heart disease patients
Not Applicable
- Conditions
- congenital heart disease with pulmonary valve insuffucency
- Registration Number
- JPRN-UMIN000018396
- Lead Sponsor
- Osaka University hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
The patient has not provided Study informed consent. The patient has active endocarditis (within the last 3 month). The patient has an abnormal calcium metabolism (e.g., chronic renal failure, hyperparathyreoidism).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the safety and durability of the transplanted decellularized heart valve 3 month after the transplantation
- Secondary Outcome Measures
Name Time Method